CEREBRAL AMYLOID ANGIOPATHY AND ALZHEIMER'S DISEASE.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Hirosaki igaku = Hirosaki medical journal

• Publication date

  2010-07-08

• Fields of study

  Medicine

• Identifiers
  PMID 21037967PMCID PMC2964669
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential activation of mitochondrial apoptotic pathways by vasculotropic amyloid‐β variants in cells composing the cerebral vessel walls

  2010cited by this paper
• Tauroursodeoxycholic acid prevents E22Q Alzheimer’s Aβ toxicity in human cerebral endothelial cells

  2009cited by this paper
• Dutch and Arctic mutant peptides of beta amyloid(1-40) differentially affect the FGF-2 pathway in brain endothelium.

  2009cited by this paper
• Amyloid precursor protein transgenic mouse models and Alzheimer's disease: Understanding the paradigms, limitations, and contributions

  2009cited by this paper
• BRI2 (ITM2b) Inhibits Aβ Deposition In Vivo

  2008cited by this paper
• Amyloid Precursor Protein Trafficking, Processing, and Function*

  2008cited by this paper
• BRI2 Inhibits Amyloid β-Peptide Precursor Protein Processing by Interfering with the Docking of Secretases to the Substrate

  2008cited by this paper
• Presenilin: running with scissors in the membrane.

  2007cited by this paper
• The Role of Cystatin C in Cerebral Amyloid Angiopathy and Stroke: Cell Biology and Animal Models

  2006cited by this paper
• The Cerebral β‐Amyloid Angiopathies: Hereditary and Sporadic

  2006cited by this paper
• The cerebral beta-amyloid angiopathies: hereditary and sporadic.

  2006cited by this paper
• Genetic alterations of the BRI2 gene: familial British and Danish dementias.

  2006cited by this paper
• Familial Danish Dementia

  2005cited by this paper
• BRI2 interacts with amyloid precursor protein (APP) and regulates amyloid beta (Abeta) production.

  2005cited by this paper
• Hereditary cerebral hemorrhage with amyloidosis‐Dutch type

  2005cited by this paper
• Amyloid associated proteins in Alzheimer's and prion disease.

  2005cited by this paper
• BRI2 Interacts with Amyloid Precursor Protein (APP) and Regulates Amyloid β (Aβ) Production*

  2005cited by this paper
• Chromosome 13 dementias

  2005cited by this paper
• The Familial Dementia BRI2 Gene Binds the Alzheimer Gene Amyloid-β Precursor Protein and Inhibits Amyloid-β Production*

  2005cited by this paper
• 3D domain‐swapped human cystatin C with amyloidlike intermolecular β‐sheets

  2005cited by this paper
• The familial dementia BRI2 gene binds the Alzheimer gene amyloid-beta precursor protein and inhibits amyloid-beta production.

  2005cited by this paper
• Alzheimer's disease is a vasocognopathy: a new term to describe its nature.

  2004cited by this paper
• Risk Factors for Vascular Dementia and Alzheimer Disease

  2004cited by this paper
• Domain swapping in N-truncated human cystatin C.

  2004cited by this paper
• The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease

  2004cited by this paper
• Aβ is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis

  2004cited by this paper
• Alzheimer's disease is a vasocognopathy: a new term to describe its nature

  2004cited by this paper
• Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence.

  2003cited by this paper
• Abeta species, including IsoAsp23 Abeta, in Iowa-type familial cerebral amyloid angiopathy.

  2003cited by this paper
• Aβ species, including IsoAsp23 Aβ, in Iowa-type familial cerebral amyloid angiopathy

  2003cited by this paper
• Contribution of wild‐type transthyretin to hereditary peripheral nerve amyloid

  2003cited by this paper
• Neurotoxic, Redox-competent Alzheimer's β-Amyloid Is Released from Lipid Membrane by Methionine Oxidation*

  2003cited by this paper
• Cerebral amyloid angiopathy and dementia: two amyloids are worse than one.

  2002cited by this paper
• Pyroglutamate‐modified amyloid β‐peptides – AβN3(pE) – strongly affect cultured neuron and astrocyte survival

  2002cited by this paper
• Amyloidosis and Alzheimer's disease.

  2002cited by this paper
• Pyroglutamate-modified amyloid beta-peptides--AbetaN3(pE)--strongly affect cultured neuron and astrocyte survival.

  2002cited by this paper
• Isoaspartate formation at position 23 of amyloid beta peptide enhanced fibril formation and deposited onto senile plaques and vascular amyloids in Alzheimer's disease

  2002cited by this paper
• Familial Danish Dementia: A Novel Form of Cerebral Amyloidosis Associated with Deposition of Both Amyloid‐Dan and Amyloid‐Beta

  2002cited by this paper
• Complement Activation in Chromosome 13 Dementias

  2002cited by this paper
• Cerebral amyloid angiopathy and cognitive function: The HAAS autopsy study

  2002cited by this paper
• Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's A beta(1--42) and A beta(25--35).

  2001cited by this paper
• Spontaneous Hemorrhagic Stroke in a Mouse Model of Cerebral Amyloid Angiopathy

  2001cited by this paper
• Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia.

  2001cited by this paper
• Cerebral microvascular pathology in aging and Alzheimer's disease.

  2001cited by this paper
• Dementia in hereditary cerebral hemorrhage with amyloidosis‐Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles

  2001cited by this paper
• Comparative Analysis of Amyloid-β Chemical Structure and Amyloid Plaque Morphology of Transgenic Mouse and Alzheimer's Disease Brains*

  2001cited by this paper
• Age-dependent deamidation of asparagine residues in proteins.

  2001cited by this paper
• Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping

  2001cited by this paper
• Elements of cerebral microvascular ischaemia.

  2001cited by this paper
• Systemic Amyloid Deposits in Familial British Dementia*

  2001cited by this paper
• Deamidation of human proteins

  2001cited by this paper
• Different Mechanisms of Oxidative Stress and Neurotoxicity for AlzheimersA ‚(1-42) and A‚(25-35)

  2001cited by this paper
• Apoptosis in neurodegenerative disorders

  2000cited by this paper
• Cerebral Beta Amyloid Angiopathy Is a Risk Factor for Cerebral Ischemic Infarction. A Case Control Study in Human Brain Biopsies

  2000cited by this paper
• Review: immunoglobulin light chain amyloidosis--the archetype of structural and pathogenic variability.

  2000cited by this paper
• Amyloid beta protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain.

  2000cited by this paper
• Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage.

  2000cited by this paper
• Amyloid β protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain

  2000cited by this paper
• Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin.

  2000cited by this paper
• Amyloidogenesis in Familial British Dementia Is Associated with a Genetic Defect on Chromosome 13

  2000cited by this paper
• A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred.

  2000cited by this paper
• Deamidation and Isoaspartate Formation in Smeared Tau in Paired Helical Filaments

  1999cited by this paper
• Analysis of transthyretin amyloid fibrils from vitreous samples in familial amyloidotic polyneuropathy (Val30Met).

  1999cited by this paper
• Hereditary cerebral hemorrhage with amyloidosis--Dutch type (HCHWA-D): a review of the variety in phenotypic expression.

  1999cited by this paper
• A stop-codon mutation in the BRI gene associated with familial British dementia

  1999cited by this paper
• Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease.

  1999cited by this paper
• Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of A beta peptides of Alzheimer's disease.

  1998cited by this paper
• Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

  1998cited by this paper
• Brain infarction and the clinical expression of Alzheimer disease. The Nun Study.

  1997cited by this paper
• Apoptosis in neurodegenerative disorders.

  1997cited by this paper
• Brain infarction and the clinical expression of Alzheimer disease.

  1997cited by this paper
• Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene

  1997cited by this paper
• The length of Amyloid-β in Hereditary Cerebral Hemorrhage with Amyloidosis, Dutch Type

  1996cited by this paper
• Apolipoprotein J and Alzheimer's amyloid beta solubility.

  1996cited by this paper
• The “Nonamyloidogenic” p3 Fragment (Amyloid β17-42) Is a Major Constituent of Down's Syndrome Cerebellar Preamyloid*

  1996cited by this paper
• The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Implications for the role of amyloid-beta 1-42 in Alzheimer's disease.

  1996cited by this paper
• Insoluble wild–type and protease–resistant mutant prion protein in brains of patients with inherited prion disease

  1996cited by this paper
• Association of apolipoprotein E with murine amyloid A protein amyloid.

  1995cited by this paper
• Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension.

  1995cited by this paper
• Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis.

  1995cited by this paper
• Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques.

  1995cited by this paper
• Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis.

  1995cited by this paper
• Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

  1994cited by this paper
• Isoform-specific binding of apolipoprotein E to beta-amyloid.

  1994cited by this paper
• Enhanced aggregation and beta structure of amyloid beta peptide after coincubation with C1q.

  1994cited by this paper
• A monoclonal antibody recognizing apolipoprotein E peptides in systemic amyloid deposits.

  1994cited by this paper
• Enhanced aggregation and β structure of amyloid β peptide after coincubation with C1Q

  1994cited by this paper
• Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro.

  1994cited by this paper
• Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments.

  1994cited by this paper
• Potential role of apolipoprotein-E in fibrillogenesis.

  1994cited by this paper
• Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging.

  1994cited by this paper
• Modifications of transthyretin in amyloid fibrils: analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation.

  1993cited by this paper
• beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease.

  1993cited by this paper
• Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease.

  1993cited by this paper
• Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid.

  1992cited by this paper
• Mass spectrometry of purified amyloid beta protein in Alzheimer's disease.

  1992cited by this paper
• Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders

  1991cited by this paper
• Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

  1991cited by this paper
• Expression of a normal and variant Alzheimer's beta-protein gene in amyloid of hereditary cerebral hemorrhage, Dutch type: DNA and protein diagnostic assays.

  1990cited by this paper
• Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.

  1990cited by this paper

• Coexisting Subdural Hematoma in Cerebral Amyloid Angiopathy: A Case Series

  2025cites this paper
• Towards Better and More Valid Zebrafish Models of Alzheimer's Disease: A Scientific Tribute to Prof. Mikhail I. Aghajanov

  2025cites this paper
• The heart-brain axis: unraveling the interconnections between cardiovascular and Alzheimer’s diseases

  2025cites this paper
• Cerebrospinal Fluid Erythrocyte Burden Amplifies the Impact of PTAU on Entorhinal Degeneration in Alzheimer’s Disease

  2025cites this paper
• Platelet COX and LOX Enzymes Orchestrate Amyloid-β Secretion via RhoA Signaling: Implications for Neurodegenerative Diseases.

  2025cites this paper
• Occult Amyloid-β-Related Angiitis: Neuroimaging Findings at 1.5T, 3T, and 7T MRI

  2024cites this paper
• Functionally distinct pericyte subsets differently regulate amyloid‐β deposition in patients with Alzheimer's disease

  2024cites this paper
• Lecanemab: A Second in Class Therapy for the Management of Early Alzheimer’s Disease

  2024cites this paper
• Imaging of Amyloid-beta-related Arteritis.

  2024cites this paper
• Disease-Modifying Treatments and Their Future in Alzheimer’s Disease Management

  2024cites this paper
• Recent Updates on Alzheimer's Disease: Pathogenesis, Pathophysiology, Molecular Approaches and Natural Bioactive Compounds Used in Contemporary Time to Alleviate Disease.

  2024cites this paper
• Role of the transcription factor NRF2 in maintaining the integrity of the Blood-Brain Barrier

  2024cites this paper
• Paying Homage to Microvessel Remodeling and Small Vessel Disease in Neurodegeneration: Implications for the Development of Late-Onset Alzheimer’s Disease

  2024cites this paper
• Unveiling tomorrow: Carbonic anhydrase activators and inhibitors pioneering new frontiers in Alzheimer's disease

  2024cites this paper
• Cooperation between neurovascular dysfunction and Aβ in Alzheimer’s disease

  2023cites this paper
• The Construction of a Multidomain Risk Model of Alzheimer’s Disease and Related Dementias

  2023cites this paper
• Pathogenesis of cerebral amyloid angiopathy caused by chaotic glymphatics—Mini-review

  2023influential citation
• A New Hypothesis for Alzheimer’s Disease: The Lipid Invasion Model

  2022cites this paper
• Hypertension and hyperhomocysteinemia as modifiable risk factors for Alzheimer's disease and dementia: New evidence, potential therapeutic strategies, and biomarkers

  2022cites this paper
• “FDA-approved carbonic anhydrase inhibitors reduce Amyloid β pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness”

  2022cites this paper
• The three sisters of fate: Genetics, pathophysiology and outcomes of animal models of neurodegenerative diseases.

  2022cites this paper
• Brain aging mechanisms with mechanical manifestations

  2021cites this paper
• The Role of High Triglycerides Level in Predicting Cognitive Impairment: A Review of Current Evidence

  2021cites this paper
• Induction of an effective anti-Amyloid-β humoral response in aged mice.

  2021cites this paper
• Retinal Vasculopathy in Alzheimer’s Disease

  2021cites this paper
• Is pseudoexfoliation glaucoma a neurodegenerative disorder?

  2021cites this paper
• Prion-associated cerebral amyloid angiopathy is not exacerbated by human phosphorylated tau aggregates in scrapie-infected mice expressing anchorless prion protein.

  2020cites this paper
• PREVALENCE OF CEREBRALAMYLOID ANGIOPATHY (CAA)-RETROSPECTIVE SINGLE CENTRE ANALYSIS FROM 2009 TO 2019

  2020cites this paper
• Alzheimer’s Retinopathy: Seeing Disease in the Eyes

  2020cites this paper
• Longitudinal Cognitive Decline in a Novel Rodent Model of Cerebral Amyloid Angiopathy Type-1

  2020cites this paper
• An exploration of the outcomes and experiences of people living with cognitive impairment and intracerebral haemorrhage : a mixed methods approach

  2019cites this paper
• Getting to the Heart of Alzheimer Disease

  2019cites this paper
• Increased expression of heme-binding protein 1 early in Alzheimer's disease is linked to neurotoxicity

  2019cites this paper
• Computational modeling and biomarker studies of pharmacological treatment of Alzheimer's disease

  2018cites this paper
• Identifying stage-specific markers of Alzheimer's disease using quantitative proteomics.

  2018cites this paper
• Restoring microglial and astroglial homeostasis using DNA immunization in a Down Syndrome mouse model

  2018cites this paper
• Cerebrovascular β‐amyloid deposition and associated microhemorrhages in a Tg2576 Alzheimer mouse model are reduced with a DHA‐enriched diet

  2018influential citation
• Angiopoietin like-4 as a novel vascular mediator in capillary cerebral amyloid angiopathy

  2018cites this paper
• Sleep and Alzheimer's disease: A pivotal role for the suprachiasmatic nucleus.

  2017cites this paper
• Identification of a New Function of Cardiovascular Disease Drug 3-Morpholinosydnonimine Hydrochloride as an Amyloid-β Aggregation Inhibitor

  2017cites this paper
• The Amyloid Hypothesis: Is There a Role for Anti-amyloid Treatment in Late-Life Depression?

  2016cites this paper
• Amyloid Hypothesis: Is There a Role for Antiamyloid Treatment in Late-Life Depression?

  2016cites this paper
• The potential role of perlecan domain V as novel therapy in vascular dementia

  2015cites this paper
• Do angiotensin receptor blockers prevent Alzheimer's disease?

  2013cites this paper
• Deposition of collagen IV and aggrecan in leptomeningeal arteries of hereditary brain haemorrhage with amyloidosis.

  2013cites this paper
• Magnetic Resonance Imaging Based Clinical Research in Alzheimer's Disease

  2012cites this paper
• Creatine affects in vitro electrophysiological maturation of neuroblasts and protects them from oxidative stress

  2012cites this paper
• Plasma Aβ and PET PiB binding are inversely related in mild cognitive impairment

  2011cites this paper
• Oxidative Stress and β-Amyloid Protein in Alzheimer’s Disease

  2011cites this paper